Dacotinib side effects include diarrhea, rash, onychomycosis, stomatitis, decreased appetite, dry skin, weight loss, hair loss, cough and itching.
Dacotinib is an EGFR-targeted drug used to treat patients with locally advanced or metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R substitution mutation. Its most common adverse reactions include diarrhea, rash, onychomycosis, stomatitis, decreased appetite, dry skin, weight loss, alopecia, cough and pruritus.
More serious adverse reactions include severe diarrhea, interstitial lung disease, etc. Depending on the severity of these adverse reactions, it may be necessary to reduce the dosage or discontinue the drug.
Contraindications: Dacotinib is contraindicated in people who are allergic to Dacotinib, if serious adverse reactions occur, it is recommended to go to the hospital to adjust the treatment.
It is recommended to use the drug under the guidance of a doctor, do not use the drug blindly. If there is any discomfort, consult the doctor in time, make a clear diagnosis, and actively treat it.